Account
Sign In
Home
Daily Diary
Asset Class
Fixed Income
Currencies
US Equity
Specialty
Global Equity & Income
Commodities
Sectors
Healthcare
Financial Services
Basic Materials
Consumer Cyclicals
Telecom Services
Energy
Transportation
Consumer Staples
Industrials
Utilities
Technology
Real Estate
Latest
Columnist Conversation
Video
Street Notes
Authors
Bruce Kamich
Jim Cramer
Jim "Rev Shark" DePorre
Brian Sozzi
Helene Meisler
Jonathan Heller
Roger Arnold
- See All -
Options
RMPIA
Switch Product
Action Alerts PLUS
Daily Swing Trade Archive
Income Seeker
Quant Ratings
Retirement
Stocks Under $10
TheStreet
Top Stocks
Trifecta Stocks
Information Provided By:
Visit TheFly.com
TheFly.com Free Trial
Fly News Breaks for November 27, 2018
RCKT
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Rocket Pharmaceuticals initiated with an Outperform at Leerink
Nov 27, 2018 | 16:33 EDT
Leerink analyst Mani Foroohar initiated Rocket Pharmaceuticals with an Outperform rating and a price target of $22.
News For RCKT From the Last 2 Days
RCKT
Get Breaking Institutional Stock News For
Free
with a 14 day trial
Rocket Pharmaceuticals names Aaron Ondrey as new CFO
Mar 26, 2024 | 16:03 EDT